| Literature DB >> 33416494 |
David W Hawman1, Kimberly Meade-White1, Shanna Leventhal1, Friederike Feldmann1, Atsushi Okumura1, Brian Smith2, Dana Scott3, Heinz Feldmann1.
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne febrile illness with wide geographic distribution. CCHF is caused by infection with the Crimean-Congo hemorrhagic fever virus (CCHFV) and case fatality rates can be as high as 30%. Despite causing severe disease in humans, our understanding of the host and viral determinants of CCHFV pathogenesis are limited. A major limitation in the investigation of CCHF has been the lack of suitable small animal models. Wild-type mice are resistant to clinical isolates of CCHFV and consequently, mice must be deficient in type I interferon responses to study the more severe aspects of CCHFV. We report here a mouse-adapted variant of CCHFV that recapitulates in adult, immunocompetent mice the severe CCHF observed in humans. This mouse-adapted variant of CCHFV significantly improves our ability to study host and viral determinants of CCHFV-induced disease in a highly tractable mouse model.Entities:
Keywords: CCHFV; Crimean-Congo hemorrhagic fever virus; immunology; infectious disease; inflammation; microbiology; mouse model; virus
Mesh:
Substances:
Year: 2021 PMID: 33416494 PMCID: PMC7811403 DOI: 10.7554/eLife.63906
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140